Learn more

RHODE ISLAND HOSPITAL

Overview
  • Total Patents
    292
  • GoodIP Patent Rank
    16,280
  • Filing trend
    ⇩ 75.0%
About

RHODE ISLAND HOSPITAL has a total of 292 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 1977. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNIV DALIAN MEDICAL, BARNES JEWISH HOSPITAL and CEDARS SINAI MEDICAL CENTER.

Patent filings per year

Chart showing RHODE ISLAND HOSPITALs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wands Jack R 75
#2 Chen Qian 25
#3 De La Monte Suzanne 19
#4 De La Monte Suzanne M 19
#5 Chen Yupeng 15
#6 Yu Hongchuan 15
#7 De La Monte Suzanne Marie 15
#8 Jay Gregory D 15
#9 Wands Jack Raymond 15
#10 Carlson Rolf I 14

Latest patents

Publication Filing date Title
US2021052561A1 Targeting aspartate beta-hydroxylase suppresses tumor malignancy and metastasis
US2020378974A1 Marker for gastrointestinal tumors
US2020268693A1 Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide
WO2020123912A1 Inhibition of asph expressing tumor growth and progression
WO2020096965A1 Malaria antigens on the surface of erythrocytes and merozoites and protective antibodies
US2019322633A1 Stromal derived factor inhibition and cxcr4 blockade
WO2019217973A1 Compositions and methods for treating articulating joint disorders with nucleoside reverse transcriptase inhibitors
WO2019217450A1 Anti-chi3l1 antibodies for the detection and/or treatment of nonalcoholic fattly liver disease/nonalcoholic steatohepatitis and subsequent complications
US2021023117A1 In vitro and in vivo intracellular delivery of sirna via self-assembled nanopieces
EP3758687A1 Exosome targeting of cd4+ expressing cells
WO2020176067A1 Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide
WO2018204404A1 Non-invasive measurement to predict post-surgery anterior cruciate ligament success
US2020113972A1 Vegf gene therapy for tendon and ligament injuries
US2019375819A1 Glycosylated transferrin receptor 1 tumor antigen
US2019151382A1 Probiotic bacteria-directed prevention or treatment of fungal infection
EP3490436A1 Methods for detecting and treating pain using brain activity
CA3016592A1 Targeting microrna for cancer treatment
CA3016210A1 Cartilage-derived progenitor cell lines
US2018094317A1 Diagnostics for pulmonary arterial hypertension and sudden cardiac death
WO2017031342A1 Circulating biomarker for brugada syndrome